Cleared Traditional

K003744 - ENRAF-NONIUS ENDOMED 182 SYSTEM

K003744 is an FDA 510(k) clearance for ENRAF-NONIUS ENDOMED 182 SYSTEM, manufactured by Henley Healthcare, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 443-day FDA review.

K003744 · Henley Healthcare, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2002
Decision
443d
Days
Class 2
Risk

K003744 is an FDA 510(k) clearance for the ENRAF-NONIUS ENDOMED 182 SYSTEM. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Henley Healthcare, Inc. (Sugar Land, US). The FDA issued a Cleared decision on February 20, 2002 after a review of 443 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Henley Healthcare, Inc. devices

FDA 510(k) Submission Details - K003744

510(k) Number K003744 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 2000
Decision Date February 20, 2002
Days to Decision 443 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
294d slower than avg
Panel avg: 149d · This submission: 443d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 349
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K003744.
TRUWAVE
K013210 · Dan Med, Inc. · Apr 2002
RELIEFBAND DEVICE, MODELS RB-DL, RB-EL, RB-RL
K020180 · Woodside Biomedical, Inc. · Mar 2002
CLASSIC TENS
K020437 · Care Rehab, Inc. · Mar 2002
APEX MEDICAL MINI TENS
K020032 · Apex Medical Corp. · Jan 2002
MODEL7500 MICROCURRENT TENS DEVICE, MCT-F5, MCT-F50, MCT-F500
K013167 · Newcare Products, LLC · Jan 2002
COSMO TENS PF-990 MINI DIGITAL WIRELESS PATCH
K013507 · Cosmo Health, Inc. · Jan 2002